Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure–activity relationship modeling (Q57819324)

quantitative structure–activity relationship (QSAR)

inferred from title

1 reference

Elisabetta Gabano

7

0 references

Ester Papa

Ester Papa

2

0 references

Paola Gramatica

Paola Gramatica

1

0 references

Mauro Ravera

Mauro Ravera

6

0 references

Domenico Osella

Domenico Osella

9

0 references

Marzia B Gariboldi

5

Marzia B. Gariboldi

0 references

Luca Gaviglio

8

Luca Gaviglio

0 references

author name string

Mara Luini

3

0 references

Elena Monti

Journal of Biological Inorganic Chemistry

4

0 references

publication date

6 June 2010

0 references

published in

0 references

volume

15

0 references

issue

7

0 references

page(s)

1157-1169

0 references

cites work

Chromatographic retention parameters in medicinal chemistry and molecular pharmacology

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00775-010-0676-4

The Problem of Overfitting

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00775-010-0676-4

The rational design of anticancer platinum complexes: the importance of the structure-activity relationship

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The relevance of polar surface area (PSA) in rationalizing biological properties of several cis-diamminemalonatoplatinum(II) derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Determination of hydrophobic parameters by reversed-phase liquid chromatography: theory, experimental techniques, and application in studies on quantitative structure-activity relationships

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The RP-HPLC measurement and QSPR analysis of logP(o/w) values of several Pt(II) complexes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The mechanism of action of platinum anticancer agents--what do we really know about it?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2].

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The EORTC Phase II study of iproplatin in advanced osteogenic sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Calculation of the Hydrophobicity of Platinum Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Basis for design and development of platinum(IV) anticancer complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Synthesis, characterization, and antitumor activity of new platinum(IV) trans-carboxylate complexes: crystal structure of [Pt(cis-1,4-DACH)trans-(acetate)2Cl2]

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Activity of JM9 in advanced ovarian cancer: a phase I-II trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

The development of platinum compounds and their possible combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020

Comments on the Definition of theQ2Parameter for QSAR Validation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20526854

12 December 2020